Time to resolution of iodine‐123 metaiodobenzylguanidine (123I‐MIBG) avidity and local control outcomes for high‐risk neuroblastoma following radiation therapy
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Imaging and Radiation Oncology"
DOI: 10.1111/1754-9485.13487
Abstract: 123I‐MIBG scan is used in neuroblastoma (NB) to monitor treatment response. Time to resolution of 123I‐MIBG avidity after radiation therapy (RT) is unknown. We sought to determine time to resolution of 123I‐MIBG avidity after RT… read more here.
Keywords: mibg avidity; 123i mibg; time resolution;